Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546721 - 546740 out of 553685 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,2M | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,2M | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 150MG/ML INJ,SOLN | 2 x 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 150MG/ML INJ,SOLN | 2 x 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 60MG/ML INJ,SOLN | 2 x 7.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 60MG/ML INJ,SOLN | 2 x 7.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 20MG/ML INJ,SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 20MG/ML INJ,SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 100MG/ML INJ,PEN 1ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 100MG/ML INJ,PEN 1ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 100MG/ML INJ,PEN 1ML | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
Pages
